proteases inhibitors
Showing 1 - 25 of 4,234
Respiratory Cathepsins, Proteases Inhibitors and
Completed
- Mucopolysaccharidoses
- Sputum
- Tracheal aspiration
-
Angers, France
- +6 more
Jan 3, 2022
Urine Alkalinazation on Urinary Inflammatory Markers in
Completed
- Cystinuria
- +3 more
- Potassium citrate
-
Paris, Ile-de-France, FranceEurpean Georges Pompidou Hospital
Mar 21, 2022
Synovial Fluid Bank From Arthritic Patients
Recruiting
- Arthritis
-
Sherbrooke, Quebec, CanadaCentre hospitalier universitaire de Sherbrooke
Nov 11, 2022
COVID-19 Trial (Drug: Isotretinoin plus Tamoxifen, Aerosolized Isotretinoin plus Tamoxifen)
Not yet recruiting
- COVID-19
- Drug: Isotretinoin plus Tamoxifen
- Aerosolized Isotretinoin plus Tamoxifen
- (no location specified)
Jul 10, 2021
Oxygen Toxicity, Pulmonary Injury, Acute Lung Injury Trial in Belfast (Liquid oxygen, medical air)
Not yet recruiting
- Oxygen Toxicity
- +2 more
- Liquid oxygen
- medical air
-
Belfast, United KingdomBelfast Health and Social Care Trus
Jul 22, 2022
HIV Patients Trial in France (No intervention)
Completed
- HIV Patients
- No intervention
-
Créteil, France
- +5 more
Jul 30, 2021
Clearance of Vasoactive Metabolites With Blood Purification
Not yet recruiting
- Critically Ill Patients
-
Garches, France
- +1 more
Oct 27, 2023
Digestive Health, Gastrointestinal Health, Appetitive Behavior Trial in Montréal (OPTIZIOME® P³ HYDROLYZER® - WHEY, Placebo)
Not yet recruiting
- Digestive Health
- +2 more
- OPTIZIOME® P³ HYDROLYZER® - WHEY
- Placebo
-
Montréal, Quebec, CanadaMcGill University, Currie Gymnasium (Exercise Metabolism and Nut
Jul 21, 2023
Vacuolar ATPase and Drug Resistance of High Grade Gliomas
Recruiting
- Glioblastoma Multiforme
-
Monza, ItalyAzienda Socio Sanitaria Territoriale Monza - Ospedale San Gerard
Apr 11, 2022
COVID-19 Pneumonia Trial in Fuenlabrada (Imatinib tablets, Baricitinib Oral Tablet, Supportive tratment)
Active, not recruiting
- COVID-19 Pneumonia
- Imatinib tablets
- +2 more
-
Fuenlabrada, Madrid, SpainHospital Universitario de Fuenlabrada
Aug 2, 2021
Myeloid Malignancy, Acute Myeloid Leukemia Trial in Cleveland (Venetoclax, Decitabine)
Not yet recruiting
- Myeloid Malignancy
- Acute Myeloid Leukemia
-
Cleveland, OhioUniversity Hospitals Seidman Cancer, Case Comprehensive Cancer C
Nov 8, 2023
Keloid Trial in Beijing (68Ga-FAPI, (68)Ga-RGD)
Recruiting
- Keloid
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Mar 2, 2022
Dental Caries Trial in Cairo (Peptide)
Completed
- Dental Caries
-
Cairo, EgyptFaculty of Dentistary - Al-Azhar University
Jan 4, 2023
CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)
Not yet recruiting
- CLL/SLL
- lisaftoclax +BTK inhibitor
- BTK inhibitor
- (no location specified)
Oct 26, 2023
Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)
Recruiting
- Acute Myeloid Leukemia
- Venclexta 100 MG Oral Tablet
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital with Nanjing Medical University
Jun 11, 2023
Myelofibrosis Trial in Jinan (TQ05105 tablets, Itraconazole capsule, Rifampicin Capsule)
Not yet recruiting
- Myelofibrosis
- TQ05105 tablets
- +2 more
-
Jinan, Shandong, ChinaShandong Provincial Hospital
Aug 30, 2023
Advanced Breast Cancer Trial in Beijing (The combination of Dalpiciclib with physician-selected endocrine therapy, Chemotherapy
Recruiting
- Advanced Breast Cancer
- The combination of Dalpiciclib with physician-selected endocrine therapy
- Chemotherapy selected by the physician
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
May 22, 2023
Musculoskeletal Health in Breast Cancer During Aromatase
Recruiting
- Musculoskeletal Health
- No intervention
-
Shanghai, Shanghai, ChinaSchool of Nursing, Fudan University
Jun 16, 2023
SGLT-2 Inhibitors on Epicardial Adipose Tissue and Cardiac
Recruiting
- Coronary Artery Disease
- Sodium Glucose Co-transporter 2 (SGLT2) Inhibitor
-
Shah Alam, Selangor, MalaysiaInstitute for Clinical Research, National Institutes of Health,
Nov 9, 2023
Bile Acids in Acute Insulin Resistance
Recruiting
- PI3K Gene Mutation
- +4 more
- Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
-
New York, New YorkColumbia University Medical Center
Oct 6, 2022
ICIs Plus Angiogenesis Inhibitors for Treatment of Advanced
Completed
- NSCLC
- Immune checkpoint inhibitors plus angiogenesis inhibitors
- Immune checkpoint inhibitors without angiogenesis inhibitors
-
Suzhou, Jiangsu, ChinaThe Affiliated Suzhou Hospital of Nanjing Medical University
Jan 17, 2023
Breast Feeding, Hypertension, Heart Failure Trial in Leuven (Venipuncture)
Recruiting
- Breast Feeding
- +3 more
- Venipuncture
-
Leuven, Vlaams-Brabant, BelgiumUniversitaire Ziekenhuizen Leuven
Oct 12, 2023
Acute Esophageal Variceal Hemorrhage Trial in Hanzhou (Growth Inhibitor)
Recruiting
- Acute Esophageal Variceal Hemorrhage
- Growth Inhibitor
-
Hanzhou, Zhejiang, China2nd Affiliated Hospital, School of Medicine, Zhejiang University
Aug 22, 2023